Consistent with the modern version of the dopamine hypothesis of schizophrenia [4,5], it is likely that increased striatal D2 receptor binding in unaffected cotwins of patients with schizophrenia is secondary to abnormal regulation of subcortical dopamine by cortical and hippocampal afferents, rather than being a primary pathological change.